122 related articles for article (PubMed ID: 14564456)
1. Heat-induced immunoreactivity of tau protein in neocortical neurons of fire fatalities.
Kibayashi K; Shojo H
Int J Legal Med; 2003 Oct; 117(5):282-6. PubMed ID: 14564456
[TBL] [Abstract][Full Text] [Related]
2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
3. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
Vickers JC; Tan A; Dickson TC
Brain Res; 2003 May; 971(1):135-7. PubMed ID: 12691846
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.
Woodhouse A; Vickers JC; Dickson TC
Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
6. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear ubiquitin immunoreactivity in the pigmented neurons of the substantia nigra in fire fatalities.
Quan L; Zhu BL; Oritani S; Ishida K; Fujita MQ; Maeda H
Int J Legal Med; 2001; 114(6):310-5. PubMed ID: 11508795
[TBL] [Abstract][Full Text] [Related]
8. Top-Down Projections Direct the Gradual Progression of Alzheimer-Related Tau Pathology Throughout the Neocortex.
Braak H; Del Tredici K
Adv Exp Med Biol; 2019; 1184():291-303. PubMed ID: 32096045
[TBL] [Abstract][Full Text] [Related]
9. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
10. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.
Blazquez-Llorca L; Garcia-Marin V; Merino-Serrais P; Ávila J; DeFelipe J
J Alzheimers Dis; 2011; 26(4):683-98. PubMed ID: 21677375
[TBL] [Abstract][Full Text] [Related]
11. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
12. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
13. Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease.
Cupidi C; Capobianco R; Goffredo D; Marcon G; Ghetti B; Bugiani O; Tagliavini F; Giaccone G
J Alzheimers Dis; 2010; 19(1):57-68. PubMed ID: 20061626
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration.
Uchihara T; Mizusawa H; Tsuchiya K; Kondo H; Oda T; Ikeda K
Acta Neuropathol; 1998 Dec; 96(6):553-7. PubMed ID: 9845283
[TBL] [Abstract][Full Text] [Related]
15. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
Hyman BT; Elvhage TE; Reiter J
Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase II alteration precedes tau accumulation in tangle formation.
Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
[TBL] [Abstract][Full Text] [Related]
18. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints.
Luna-Muñoz J; Peralta-Ramirez J; Chávez-Macías L; Harrington CR; Wischik CM; Mena R
Acta Neuropathol; 2008 Nov; 116(5):507-15. PubMed ID: 18810470
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
20. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.
Morawski M; Brückner G; Jäger C; Seeger G; Arendt T
Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
